STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugs
Story detail
Read the key details here, then continue on the original publisher.
In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugs
Join our channel to receive the latest headlines and breaking stories as soon as they are published.
Comments (0)
Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.
No comments yet. Be the first to share your thoughts!